14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Dec 04, 2019 $6.22 $6.72 $6.15 $6.40 617 272
Dec 03, 2019 $6.21 $6.59 $6.09 $6.51 483 186
Dec 02, 2019 $6.03 $6.19 $5.84 $6.15 794 976
Nov 29, 2019 $5.67 $6.08 $5.67 $5.95 365 650
Nov 27, 2019 $5.52 $5.83 $5.52 $5.62 508 655
Nov 26, 2019 $5.50 $5.76 $5.45 $5.50 562 112
Nov 25, 2019 $5.60 $5.64 $5.47 $5.50 370 018
Nov 22, 2019 $5.53 $5.61 $5.47 $5.54 252 904
Nov 21, 2019 $5.30 $5.51 $5.19 $5.47 176 867
Nov 20, 2019 $5.42 $5.61 $5.30 $5.32 339 852
Nov 19, 2019 $5.52 $5.72 $5.36 $5.44 227 061
Nov 18, 2019 $5.55 $5.60 $5.30 $5.52 312 619
Nov 15, 2019 $5.60 $5.66 $5.44 $5.55 269 511
Nov 14, 2019 $5.60 $5.71 $5.46 $5.60 455 134
Nov 13, 2019 $5.39 $5.68 $5.31 $5.60 295 543
Nov 12, 2019 $5.38 $5.49 $5.24 $5.41 305 580
Nov 11, 2019 $5.60 $5.62 $5.30 $5.39 470 338
Nov 08, 2019 $3.65 $5.68 $3.65 $5.63 1 119 239
Nov 07, 2019 $4.50 $4.73 $4.44 $4.70 462 774
Nov 06, 2019 $4.32 $4.50 $4.24 $4.46 173 014
Nov 05, 2019 $4.39 $4.47 $4.30 $4.32 211 185
Nov 04, 2019 $4.37 $4.50 $4.27 $4.37 298 959
Nov 01, 2019 $4.12 $4.36 $4.07 $4.34 260 808
Oct 31, 2019 $3.94 $4.12 $3.78 $4.11 205 723
Oct 30, 2019 $3.93 $4.03 $3.86 $3.94 232 007
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT